BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22173241)

  • 21. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
    Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
    Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
    Shand JC; Jansson J; Hsu YC; Campbell A; Mullen CA
    Cancer Immunol Immunother; 2010 Nov; 59(11):1633-44. PubMed ID: 20602231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
    Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
    Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.
    Mikami T; Kato I; Wing JB; Ueno H; Tasaka K; Tanaka K; Kubota H; Saida S; Umeda K; Hiramatsu H; Isobe T; Hiwatari M; Okada A; Chiba K; Shiraishi Y; Tanaka H; Miyano S; Arakawa Y; Oshima K; Koh K; Adachi S; Iwaisako K; Ogawa S; Sakaguchi S; Takita J
    Cancer Sci; 2022 Jan; 113(1):41-52. PubMed ID: 34716967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles.
    Li WY; Chen XM; Xiong W; Guo DM; Lu L; Li HY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):640-645. PubMed ID: 25318871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.
    Dawidowska M; Jaksik R; Drobna M; Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Machowska L; Lalik A; Lejman M; Ussowicz M; Kałwak K; Kowalczyk JR; Szczepański T; Witt M
    Neoplasia; 2019 Mar; 21(3):294-310. PubMed ID: 30763910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.
    Schiffman JD; Wang Y; McPherson LA; Welch K; Zhang N; Davis R; Lacayo NJ; Dahl GV; Faham M; Ford JM; Ji HP
    Cancer Genet Cytogenet; 2009 Aug; 193(1):9-18. PubMed ID: 19602459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.
    Schroeder MP; Bastian L; Eckert C; Gökbuget N; James AR; Tanchez JO; Schlee C; Isaakidis K; Häupl B; Baum K; Migueles Lozano OA; Kouidri K; Pan KT; Urlaub H; Schwartz S; Burmeister T; von Stackelberg A; Hoelzer D; Pfeiffer H; Rieger MA; Göllner S; Oellerich T; Horstman M; Schrappe M; Wolf J; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Neumann M; Baldus CD
    Sci Rep; 2019 Mar; 9(1):4188. PubMed ID: 30862934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers in ALL: Clinical implications.
    Kimura S; Mullighan CG
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101193. PubMed ID: 33038982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).
    Chaber R; Gurgul A; Wróbel G; Haus O; Tomoń A; Kowalczyk J; Szmatoła T; Jasielczuk I; Rybka B; Ryczan-Krawczyk R; Duszeńko E; Stąpor S; Ciebiera K; Paszek S; Potocka N; Arthur CJ; Zawlik I
    PLoS One; 2017; 12(11):e0187422. PubMed ID: 29125853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.
    Cleaver AL; Beesley AH; Firth MJ; Sturges NC; O'Leary RA; Hunger SP; Baker DL; Kees UR
    Mol Cancer; 2010 May; 9():105. PubMed ID: 20459861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
    Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
    Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
    Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
    Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
    van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
    Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
    Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
    Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway.
    Cao J; Li L; Chen C; Lv C; Meng F; Zeng L; Li Z; Wu Q; Zhao K; Pan B; Cheng H; Chen W; Xu K
    Leuk Res; 2013 Sep; 37(9):1170-7. PubMed ID: 23683786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital gene expression profiling analysis of childhood acute lymphoblastic leukemia.
    Zhao MY; Yu Y; Xie M; Yang MH; Zhu S; Yang LC; Kang R; Tang DL; Zhao LL; Cao LZ
    Mol Med Rep; 2016 May; 13(5):4321-8. PubMed ID: 27053012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterization of human B cell precursor-leukemia cell lines.
    Matsuo Y; Drexler HG
    Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.